Feature Channels: Vaccines

• share
• favorite_border

The University of Miami Health System is one of five sites nationally and the only one in the Southeast U.S. chosen to participate in a National Institute of Allergy and Infectious Diseases (NIAID) study looking at people who have had COVID-19 or have had a COVID-19 vaccine to examine the durability and robustness of participants’ antibody and T-cell responses to the virus.

• share
• favorite_border

A Woman’s Journey will host a 90-minute virtual event, “COVID-19: One Year Later,” during which Johns Hopkins Medicine experts will address important issues related to COVID-19 such as new and available treatments and vaccine safety and efficacy. Registrants will learn about the continued urgency of public health measures to mitigate the pandemic despite the introduction of vaccines, what distinguishes the leading vaccine contenders in their methodology, safety and effectiveness, and symptoms and insights surrounding lingering deficits in physical function, mental health and cognition among COVID-19 survivors.

• share
• favorite_border

At 30 weeks pregnant, most women would be putting the finishing touches on the nursery, rounding up remaining baby gear, and packing their hospital bag. But Jacqueline Parchem, MD, was faced with an additional task – deciding whether to receive the COVID-19 vaccine despite limited data for pregnant women.

• share
• favorite_border

In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine.

• share
• favorite_border

The National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the Centers for Disease Control and Prevention in the first week of use of the Pfizer-BioNTech COVID-19 vaccine in the United States.

• share
• favorite_border

New coronavirus strains — some more contagious than the prevalent strain — continue to be identified across the globe. David Cennimo, a pediatric infectious disease expert and assistant professor at Rutgers New Jersey Medical School, discusses what we know about the new variants and how to stay safe.

• share
• favorite_border

Staff, patient and community COVID-19 vaccine updates from Keck Medicine of USC

• share
• favorite_border

Provincial and territorial governments should set clear rules for vaccinating health care workers against SARS-CoV-2, the virus that causes COVID-19, in public and private settings, and should not leave this task to employers, according to an analysis in CMAJ (Canadian Medical Association Journal).

• share
• favorite_border

Developed by a research team led by Maurizio Porfiri, Institute Professor at the NYU Tandon School of Engineering, a novel open-source platform comprises an agent-based model (ABM) of COVID-19 for the entire town of New Rochelle, in Westchester County, New York State.

• share
• favorite_border

Scientists have shown that two species of seasonal human coronavirus related to SARS-CoV-2 can evolve in certain proteins to escape recognition by the immune system, according to a study published today in eLife.

• share
• favorite_border

Cornell University is partnering with New York state and Northwell Health System to develop and train the nation’s first state public health corps, which will support COVID-19 vaccination and improve long-term public health outcomes.

• share
• favorite_border

ConserV Bioscience Limited (CBL) and Lawrence Livermore National Laboratory (LLNL) have agreed to collaborate on the development of a broad-spectrum or “universal” coronavirus vaccine.

• share
• favorite_border

The Front Line COVID-19 Critical Care Alliance (FLCCC) has issued a public response to the National Institutes of Health (NIH) regarding the NIH COVID-19 Treatment Guidelines Panel’s “neither for nor against” recommendation for the use of ivermectin in the treatment of COVID-19.

• share
• favorite_border

If pregnant individuals catch COVID they will generally get sicker than non-pregnant individuals. They also more commonly end up on ECMO [heart-lung support], in the ICU or on ventilators.

• share
• favorite_border

Even people who have experienced severe allergic reactions to food, latex, pets, pollen, or bee stings should get the coronavirus vaccine, UW Medicine allergy and infectious disease experts say.

• share
• favorite_border

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

• share
• favorite_border

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

• share
• favorite_border

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

• share
• favorite_border

AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.

• share
• favorite_border

The NEJM paper actually states that the efficacy between the first and second doses was found to be 52 percent when given 21 days apart. After the second dose, the efficacy raises to 95 percent.

• share
• favorite_border

As a new, apparently more transmissible version of the virus that causes COVID-19 has appeared in several countries, new research finds that the transmissibility of viral strains and the population density of a region will play big roles in how vaccination campaigns can help towns and cities return to more normal activities. The findings suggest that directing vaccines toward densely populated counties would help to interrupt transmission of the disease.

• share
• favorite_border

Experts will discuss and take questions on COVID-19 vaccine distribution.

• share
• favorite_border

• share
• favorite_border

The Academy of Breastfeeding Medicine (ABM) does not recommend cessation of breastfeeding for individuals who are vaccinated against COVID-19.

• share
• favorite_border

Health behaviors and emotional stressors can alter the body’s ability to develop an immune response to vaccines, including—potentially—the new COVID-19 vaccines. Simple interventions, including exercising and getting a good night’s sleep in the 24 hours before vaccination, may maximize the vaccine’s initial effectiveness.

• share
• favorite_border

While we wait for our turn to get vaccinated against SARS-CoV-2, we could – and probably should – use the time to make sure we bring our healthiest emotional and physical selves to the treatment, a new review of previous research suggests.

• share
• favorite_border

Nearly half of summer camps surveyed by researchers didn’t have official policies requiring campers be vaccinated, according to findings led by Michigan Medicine C.S. Mott Children’s Hospital in JAMA Pediatrics. Of 378 camps represented, just 174 reportedly had immunization policies for campers and 133 (39%) mandated staffers be vaccinated.

• share
• favorite_border

• share
• favorite_border

With months to go in the mass rollout of COVID-19 vaccines, testing is still critical to control the surging pandemic.

• share
• favorite_border

What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation?

• share
• favorite_border

• share
• favorite_border

As the vaccine becomes available to older adults, and case of COVID-19 surge, a list of key tips and relevant links for older adults about getting through this winter safely and healthily.

• share
• favorite_border

Argonne scientists and research facilities have made a difference in the fight against COVID-19 in the year since the first gene sequence for the virus was published.

• share
• favorite_border

As the first doses of COVID-19 vaccines are being rolled out, it is still unclear whether enough Americans are willing to be vaccinated to allow the nation to return to normalcy.

• share
• favorite_border

Is the COVID-19 vaccine safe for people with food allergies? Two infectious disease experts offer answers and explain how the body accepts the vaccine in this week’s Penn State Health Medical Minute.

• share
• favorite_border

• share
• favorite_border

A team of renowned scientific experts has joined forces from across the world to help fight the spread of misinformation about the COVID-19 vaccines, which hold the key to beating the deadly pandemic and releasing countries from debilitating lockdown restrictions.

• share
• favorite_border

The human papillomavirus infection, or HPV, is the most common sexually transmitted infection in the U.S., according to the Centers for Disease Control and Prevention.

• share
• favorite_border

A systematic review and meta-analysis of international COVID-19 literature, led by UNSW Sydney, has confirmed that while children under five years old were likely to recover from the infection, half of those infected were infants and almost half of the infected under-fives were asymptomatic.

• share
• favorite_border

The findings, based on analyses of blood samples from 188 COVID-19 patients, suggest that responses to the novel coronavirus, SARS-CoV-2, from all major players in the "adaptive" immune system, which learns to fight specific pathogens, can last for at least eight months after the onset of symptoms from the initial infection.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Predicting the spread of COVID-19 using standard statistical models has its challenges, which is why two Iowa State University researchers developed a network-based approach to look at the impact of specific policies and vaccination strategies throughout the many stages of the pandemic.

• share
• favorite_border

The AIDS Clinical Trials Group (ACTG) has added a new agent to the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. This phase 2 study, which is being led by the ACTG, will evaluate the combination of the two monoclonal antibodies BRII-196 and BRII-198 to treat early COVID-19.

• share
• favorite_border

• share
• favorite_border

The Johns Hopkins Carey Business School and the Hopkins Business of Health Initiative on January 25, 2021, will present a panel discussion on the COVID-19 vaccine from discovery to manufacturing to delivery.

• share
• favorite_border

Reports of possible allergic reactions to the COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, both recently approved for emergency use by the U.S. Food and Drug Administration (FDA), have raised public concern.